1. Clark, Victoria E, Erson-Omay, E Zeynep, Serin, Akdes, Yasuno, Katsuhito, Günel, Murat. 2013. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. In Science (New York, N.Y.), 339, 1077-80. doi:10.1126/science.1233009. https://pubmed.ncbi.nlm.nih.gov/23348505/
2. Kong, Kyoung-Ah, Lee, Ji-Yeon, Oh, Ji Hoon, Lee, Youra, Kim, Myoung Hee. 2014. Akt1 mediates the posterior Hoxc gene expression through epigenetic modifications in mouse embryonic fibroblasts. In Biochimica et biophysica acta, 1839, 793-9. doi:10.1016/j.bbagrm.2014.06.011. https://pubmed.ncbi.nlm.nih.gov/24955524/
3. Zhao, Jingjing, Zeng, Xue, Song, Ping, Wu, Xiaohong, Shi, Hongbo. 2016. AKT1 as the PageRank hub gene is associated with melanoma and its functional annotation is highly related to the estrogen signaling pathway that may regulate the growth of melanoma. In Oncology reports, 36, 2087-93. doi:10.3892/or.2016.5048. https://pubmed.ncbi.nlm.nih.gov/27573172/
4. Seehawer, Marco, Heinzmann, Florian, D'Artista, Luana, Bischof, Oliver, Zender, Lars. 2018. Necroptosis microenvironment directs lineage commitment in liver cancer. In Nature, 562, 69-75. doi:10.1038/s41586-018-0519-y. https://pubmed.ncbi.nlm.nih.gov/30209397/
5. George, Bijesh, Gui, Bin, Raguraman, Rajeswari, Pillai, Madhavan Radhakrishna, Kumar, Rakesh. 2022. AKT1 Transcriptomic Landscape in Breast Cancer Cells. In Cells, 11, . doi:10.3390/cells11152290. https://pubmed.ncbi.nlm.nih.gov/35892586/
6. Inoki, Ken, Li, Yong, Zhu, Tianquan, Wu, Jun, Guan, Kun-Liang. . TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. In Nature cell biology, 4, 648-57. doi:. https://pubmed.ncbi.nlm.nih.gov/12172553/
7. Heng, Jianfu, Guo, Xinwu, Wu, Wenhan, Tang, Lili, Wang, Jun. 2017. Integrated analysis of promoter mutation, methylation and expression of AKT1 gene in Chinese breast cancer patients. In PloS one, 12, e0174022. doi:10.1371/journal.pone.0174022. https://pubmed.ncbi.nlm.nih.gov/28301567/
智鼠故事 
